Biochemistry Professor Xuedong Liu's startup, OnKure Therapeutics, raises $51M in series B funding in 2021
Redirecting to: /venturepartners/about-us/2021-venture-partners-annual-report
Redirecting to: /venturepartners/about-us/2021-venture-partners-annual-report